Study: Current treatment extends colon cancer patients' lives

09/20/2007 | Yahoo!

Researchers performed a meta-analysis of 242 studies and found that irinotecan, oxaliplatin and molecular-targeted therapies can help extend the lives of patients with advanced colorectal cancer by several months compared to those who received older treatment regimens. However, experts cautioned that such drug combinations may also cause serious side effects, including gastrointestinal perforation.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX